Pharmaceutical Sector

Glenmark Gets US FDA Nod To Market ‘Lithium Carbonate’

Glenmark Gets US FDA Nod To Market ‘Lithium Carbonate’The US Food and Drug Administration (USFDA) has given its final approval to Glenmark Generics Inc. USA (GGI), the US arm of Glenmark Generics Limited (GGL), to market lithium carbonate capsules in variable strengths.

GGI will market the capsules in dosages of 150 mg, 300 mg and 600 mg.

Lithium is used for treating patients suffering from manic episodes of Bipolar Disorder. Bipolar Disorder, Manic (DSM-III) is equivalent to Manic Depressive illness, Manic, in the older DSM-II terminology.

Pfizer faces suit over Wyeth takeover

Pfizer faces suit over Wyeth takeoverNew York  - Pfizer faces a shareholder lawsuit over its takeover of multi-billion dollar rival Wyeth, with the smaller firm's stockholders alleging the deal undervalues the company, Bloomberg financial news reported Friday.

The world's largest pharmaceuticals maker Pfizer Inc announced Monday that it would purchase Wyeth in a deal worth 68 billion dollars.

The suit filed by Wyeth shareholders in a Newark, New Jersey court on Tuesday alleges the firm's directors breached their duty by not getting a better price.

AstraZeneca confirms 6,000 more jobs will be cut

AstraZeneca confirms 6,000 more jobs will be cut London  -

Venus Remedies facility gets ‘GMP certificate’

Venus Remedies facility gets ‘GMP certificate’The Chandigarh-based Venus Remedies’ manufacturing facilities at Baddi Campus has secured Good Manufacturing Practices certificate from the Ministry of Health and Medical Education of Iran which will enable the Company to export its products to Iranian market.

Technical analysts believe that this is a major breakthrough for the Company as Iran holds a significant share in Middle Eastern Pharmaceutical market and would open door to other Middle Eastern Markets as well.

Biocon’s Syngene International to offer fully integrated drug discovery service

Biocon’s Syngene International to offer fully integrated drug discovery serviceSyngene International, a unit of Indian biotechnology major BIOCON Group, has informed that it will offer fully integrated drug discovery services by partnering with Sapient Discovery, a US based Biotechnology Company.

Sapient Discovery uses integrated, proprietary computational and experimental laboratory technologies, and cellular biology and proprietary data mining to accelerate the drug discovery and optimization processes.

Dr Reddy's posts increase in net for Q3

Dr Reddy's posts increase in net for Q3Leading pharmaceutical company Dr. Reddy's Laboratories announced its financial results for the third quarter ended December 31, 08. The company posted net profit of
192.40-crore in the reporting period as compared to loss of Rs 121.30 crore in the same period last year.

Its revenue stood at Rs 1,840 crore in Q3 as compared to Rs 1,231 crore in the third quarter of financial year 2007-08.

Pages